Barbell Medicine Podcast

Barbell Medicine

Podcast by Barbell Medicine

  • 1 hour 36 minutes
    Overtraining Syndrome: Causes, Diagnosis, and What's Actually Going On

    In 2022, researchers conducted the most rigorous systematic review ever performed on overtraining syndrome — looking specifically for controlled studies that documented a human transitioning from a healthy training state to an overtrained state. Zero studies met those criteria.

     

    The word "overtrained" appears in coaching certifications, wearable device dashboards, and clinical sports medicine guidelines — and in each context it means something different. That definitional chaos has consequences: it delays real diagnoses, produces nocebo effects with measurable physiological outcomes, and leads athletes to reduce training they didn't need to reduce.


    In this episode, Drs. Jordan Feigenbaum and Austin Baraki work through the full evidence base on overtraining syndrome — the taxonomy, the attempted studies, the six competing mechanistic theories, the biomarker failures, and what's actually happening when a lifter can't make progress.

     

    Timestamps:


    • 0:00 Cold open — the zero-studies finding
    • 1:21 Why "overtrained" does four different jobs simultaneously
    • 16:10 The FOR / NFOR / OTS taxonomy
    • 19:43 The supercompensation model — borrowed from endurance, never validated for resistance training
    • 32:28 Austin's clinical differential for fatigue and declining performance
    • 36:17 RT evidence — what happens when researchers try to induce OTS through lifting
    • 43:19 Austin — what actually drives the complaints he sees in practice
    • 47:30 Six theories for what causes overtraining syndrome
    • 1:01:09 The biomarker problem — why the T:C ratio and cortisol don't work
    • 1:05:09 What your wearable is actually measuring (and what it isn't)
    • 1:09:28 Austin — testosterone levels in trained athletes and when to act
    • 1:13:40 Heart rate variability — limitations for strength training
    • 1:15:36 Session RPE — the monitoring tool that actually works
    • 1:17:31 How common is overtraining syndrome, really?
    • 1:23:04 Three failure modes — what's actually happening when lifters say they feel overtrained
    • 1:32:14 Austin — what a proper medical workup looks like
    • 1:34:22 Outro


    What we cover:


    • The definition problem — why a single word is doing four incompatible jobs simultaneously, and why that matters clinically and practically.
    • The taxonomy — functional overreaching, nonfunctional overreaching, and overtraining syndrome as points on a continuous variable that can only be identified after the fact, not at presentation.
    • The supercompensation model — where it came from, why it fails to describe how resistance training adaptation actually works, and how applying it too literally produces both overloading and underloading errors at the same time.
    • Austin's clinical differential — what a physician actually works through when a patient presents with fatigue and declining performance, and where overtraining syndrome actually sits on that list.
    • What resistance training research shows — including 140 maximal singles, 90 working sets per week, and daily 1-rep max attempts. No study has cleanly induced overtraining syndrome through resistance training. The hormonal data went in the opposite direction from what the endurance overtraining model predicts.
    • Six mechanistic theories — glycogen depletion, serotonin/BCAA, autonomic imbalance, central governor, HPA axis dysregulation, and Armstrong's complex systems framework. Each one is partially supported and each falls short.
    • The biomarker problem — resting cortisol is normal in 75%+ of OTS cases, the testosterone to cortisol ratio has never been validated against clinical outcomes as an individual diagnostic, and HRV recovery in strength training lags physical recovery by up to 30 hours.
    • Austin on wearables — including a clinical pattern he's seeing with GLP-1 receptor agonists: wearable scores indicating deterioration when the clinical picture is actually fine.
    • Session RPE as the real tool — why session RPE trending upward at stable training load is a more reliable signal of load-recovery mismatch than any biomarker currently used.
    • Prevalence and confounders — the 60% figure, why it almost certainly captures all three FOR/NFOR/OTS categories plus REDS, depression, and illness, and why the residual true training-load-induced OTS in an otherwise healthy athlete may be vanishingly rare.
    • Three failure modes — the three things Jordan actually sees in practice when lifters present saying they feel overtrained, and how to distinguish between them using session RPE.
    • The medical workup — Austin's practical walkthrough of what to assess when programming and lifestyle changes don't move the needle, including iron deficiency (ferritin testing caveats, lab reference range problems), sleep apnea, post-viral syndromes, and hormone panels done correctly.


    Next Steps:


    For evidence-based resistance training programs: barbellmedicine.com/training-programs


    For individualized training consultation: barbellmedicine.com/coaching


    Explore our full library of articles on health and performance: barbellmedicine.com/resources


    To consult with Drs. Baraki or Feigenbaum email us at [email protected]


    For ad free listening and exclusive discounts, become a Barbell Medicine Plus subscriber at https://barbellmedicine.supercast.com/


     Resources

     

    Taxonomy / Definitions

    Meeusen et al. (2013)

    European College of Sport Science / ACSM consensus statement on FOR, NFOR, and OTS taxonomy. Defines OTS as a diagnosis of exclusion.

    https://pubmed.ncbi.nlm.nih.gov/23247672/


    Meeusen et al. (2006)

    "Often only after a period of complete rest" — the retrospective nature of distinguishing NFOR from OTS.

    https://pubmed.ncbi.nlm.nih.gov/23016079/


    Nocebo Effects in Sport

    2024 Systematic Review

    Nocebo effects in sport were approximately twice the magnitude of placebo effects on performance across 20 studies.

    https://pubmed.ncbi.nlm.nih.gov/38999724/


    Stress-Recovery-Adaptation Model

    Original general adaptation syndrome / stress physiology work in Nature. Foundational source the SRA model was derived from — not a sports science paper.

    https://www.nature.com/articles/138032a0


    Multi-system adaptation timescales; critique of single-wave supercompensation model.

    https://pubmed.ncbi.nlm.nih.gov/3057313/


    Multi-system adaptation timescales; further critique of the SRA "window of opportunity" model.

    https://pubmed.ncbi.nlm.nih.gov/15044685/


    Lack of empirical support for the supercompensation "window of opportunity" in real training scenarios.

    https://pubmed.ncbi.nlm.nih.gov/29189930/


    Resistance Training and OTS

    Grandou et al. (2020)

    Systematic review: 22 studies on resistance training overtraining. 10 showed zero performance decline under deliberate overload. No reliable biomarker established for RT overtraining; sustained performance drop is the only consistent signal.

    https://pubmed.ncbi.nlm.nih.gov/31313309/


    Coleman et al. (2024)

    9-week supervised high-volume RT protocol (~90 sets/week). No OTS criteria met. Ceiling for resistance training-induced OTS is considerably higher than commonly implied.

    https://pmc.ncbi.nlm.nih.gov/articles/PMC10809978/


    Zourdos et al. (2016)

    Case series: 3 competitive strength athletes performed daily 1RM squat for 30 consecutive days. All three improved.

    https://pubmed.ncbi.nlm.nih.gov/26816276/


    Daily 1RM Bench Press Study

    7 athletes attempted a true 1RM bench press every day for 38 days. All improved despite day-to-day fluctuation.

    https://www.thefreelibrary.com/Efficacy+of+Daily+One-Repetition+Maximum+Bench+Press+Training+in...-a0828317501


    3 weeks of daily loading; volume arm hypertrophied. Daily frequency did not produce overtraining; volume drives hypertrophy, not frequency alone.

    https://pubmed.ncbi.nlm.nih.gov/27875635/


    Fry et al. (1994) — Overreaching Protocol

    Original resistance overreaching induction: 10×1 at 100% 1RM daily for 14 days. 1RM dropped ~12 kg. Hormonal response was opposite to endurance OTS profile (cortisol decreased, testosterone slightly increased).

    https://pubmed.ncbi.nlm.nih.gov/7808252/


    Fry et al. (1994) — Endurance Biomarkers

    Endurance OTS biomarkers (T:C ratio) do not apply to high-intensity resistance training overreaching.

    https://pubmed.ncbi.nlm.nih.gov/9843563/


    Fry et al. (2006)

    Same overreaching protocol with muscle biopsies. Beta-2 adrenergic receptor density in vastus lateralis decreased 37%. Orthopedic ceiling hypothesis: structural limits intervene before neuroendocrine axis fully desensitizes.

    https://pubmed.ncbi.nlm.nih.gov/16888042/



    Raastad et al. (2001)

    Daily submaximal leg training for 2 weeks; 1RM increased 6%. Intensity (not frequency) is the necessary ingredient for overreaching in resistance training.

    https://pubmed.ncbi.nlm.nih.gov/11394254/



    Margonis et al. (2007)

    12-week progressive RT peaking at ~14 tonnes/week. Significant 1RM decrements not restored after 6-week taper — the only resistance training study to approach true OTS criteria.

    https://pubmed.ncbi.nlm.nih.gov/17697935/


    HPA Axis / Biomarkers


    Cadegiani & Kater (2017) — EROS Study

    Resting cortisol is normal in ≥75% of OTS studies. Reduced pituitary ACTH output (not adrenal failure) is the upstream dysregulation in OTS. "Adrenal fatigue" is mechanistically backwards.

    https://pmc.ncbi.nlm.nih.gov/articles/PMC5722782/


    EROS Study — Extended Findings

    Further EROS study data on HPA axis dysregulation patterns in OTS.

    https://pmc.ncbi.nlm.nih.gov/articles/PMC6590962/


    Testosterone: acute 30% drops occur routinely after a marathon and normalize within days. Never validated as an individual OTS diagnostic.

    https://pubmed.ncbi.nlm.nih.gov/3744643/


    Saw et al. (2016)

    56-study systematic review of athlete monitoring tools. Subjective measures (mood, perceived fatigue, sleep quality) tracked training load changes with greater sensitivity than objective markers including hormones, resting HR, and HRV.

    https://pmc.ncbi.nlm.nih.gov/articles/PMC4789708/


    Meeusen et al. (2004/2010) — Two-Bout Exercise Protocol

    Two maximal incremental tests 4 hours apart with serial blood draws. OTS athletes show blunted ACTH/prolactin response to second bout; NFOR athletes show exaggerated response. Most validated objective test available; not a field tool.

    https://pubmed.ncbi.nlm.nih.gov/18703548/


    HRV as a Monitoring Tool

    HRV for OTS detection: weak data, foundational work done in cyclists and triathletes only.

    https://pubmed.ncbi.nlm.nih.gov/23852425/



    Strength recovery occurred ~30 hours after heavy loading; HRV had not normalized at 60 hours. Using HRV as a daily training prescription tool in strength athletes is an untested assumption.

    https://pubmed.ncbi.nlm.nih.gov/21273908/



    Session RPE and Monitoring

    Foster et al. (1998)

    Session RPE method: training load quantified as RPE × session duration. Key monitoring metric throughout the episode.

    https://pubmed.ncbi.nlm.nih.gov/9662690/


    Soreness, mood, and motivation relative to training load as monitoring signals.

    https://pubmed.ncbi.nlm.nih.gov/38321325/


    Prevalence

    Morgan et al. (1987)

    The commonly cited 60% OTS prevalence figure. Retrospective self-report using the term "staleness," conducted before the current taxonomy existed. Almost certainly captures all three tiers of the FOR/NFOR/OTS continuum.

    https://pubmed.ncbi.nlm.nih.gov/3676635/



    Confounders: PED Use

    Anonymous Survey Data (2011)

    29% of Track and Field World Championship athletes admitted PED use; 45% at Pan-Arab Games.

    https://core.ac.uk/download/pdf/109992897.pdf


    Lippi et al. (2015)

    WADA detects PED use in only 1–2% of samples; USADA detection rate <1%. Elite athlete PED use is substantially underreported in the OTS literature.

    https://www.nature.com/articles/517529a



    Confounders: Psychiatric Conditions


    Armstrong & VanHeest (2002)

    Overlap between OTS and major depression. Depression can produce every OTS symptom; any OTS workup without a formal depression screen is incomplete.

    https://pubmed.ncbi.nlm.nih.gov/11839081/



    Confounders: Energy Availability


    Cadegiani et al. (2021)

    86% of OTS studies showed co-occurrence of reduced energy availability with OTS-like presentation.

    https://pubmed.ncbi.nlm.nih.gov/34181189/


    Autoregulation and RPE — Part I

    Barbell Medicine blog post on autoregulation and RPE-based programming.

    https://www.barbellmedicine.com/blog/autoregulation-and-rpe-part-i/


    Training Plateau Action Plan

    Barbell Medicine practical guide for diagnosing and addressing training plateaus.

    https://www.barbellmedicine.com/training-plateau-action-plan/


    Injury / Rehab Coaching Questionnaire

    https://www.barbellmedicine.com/coaching-questionnaire-injury-rehab/



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    31 March 2026, 4:00 pm
  • 30 minutes 34 seconds
    Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth | Direct Line March 2026 (Free)

    In this free preview of the March 2026 Direct Line AMA. Drs. Feigenbaum and Baraki cover: VO2 max versus cardiorespiratory fitness for longevity (are Peter Attia’s targets evidence-based? — with Goodhart’s Law and the JAMA evidence), what GLP-1 medications actually cost now via manufacturer programs ($149–449/month), and whether 7,000–10,000 daily steps actually meet the bar for cardiovascular training.


    Full episode for Barbell Medicine Plus subscribers at https://barbellmedicine.supercast.com/


    Timestamps:

    0:00 — Introduction

    3:26 — VO2 Max vs. Cardiorespiratory Fitness for Longevity

    14:11 — GLP-1 Costs: What you should actually be paying now

    21:43 — Is Walking Enough for Cardiovascular Health?


    Next Steps:


    For evidence-based resistance training programs: barbellmedicine.com/training-programs


    For individualized training consultation: barbellmedicine.com/coaching


    Explore our full library of articles on health and performance: barbellmedicine.com/resources


    To consult with Drs. Baraki or Feigenbaum email us at [email protected]


    Resources:


    • JAMA Network Open — Cardiorespiratory Fitness & Long-term Mortality (Mandsager et al.) — Exercise capacity (METs) and longevity — the foundational CRF/mortality study cited in the episode https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
    • JAMA — Blair et al. — Physical fitness and all-cause mortality: a prospective study of healthy men and women https://jamanetwork.com/journals/jama/fullarticle/379243
    • Barbell Medicine Vital Five — Multi-modal CRF benchmarks and longevity targets https://www.barbellmedicine.com/vital-5-action-plan/
    • Lilly Direct — Zepbound (tirzepatide) — Manufacturer direct program ($299–449/month) https://www.lillydirect.com/zepbound
    • NovoCare — Wegovy (semaglutide) — Manufacturer savings program ($149–349/month) https://www.novocare.com/patient/medicines/wegovy.html
    • Orforglipron — Eli Lilly oral GLP-1 — What to know about orforglipron (small-molecule oral GLP-1 agonist, pending FDA approval) https://www.lilly.com/news/stories/what-to-know-about-orforglipron


    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    24 March 2026, 4:00 pm
  • 44 minutes 34 seconds
    Episode #390: Why Your Waist Matters More Than Your Weight — The Science of Visceral Fat

    You can have a completely normal BMI and be on your way to cardiovascular disease, type 2 diabetes, and metabolic syndrome without triggering a single alert on a standard health screening. The fat that predicts metabolic risk most accurately isn't the fat your scale or your doctor is tracking. Dr. Jordan Feigenbaum breaks down the science of visceral fat — what it is, how it causes disease, how to measure it correctly at home for free, and what the evidence actually shows about exercise, GLP-1 medications, and testosterone.


    Timestamps:


    • 00:00:00 Cold Open: The Visceral Fat Finding
    • 00:00:49 The Scale Problem — What Body Weight Actually Measures
    • 00:03:50 What Is Visceral Fat — and Why It's Not Just "Belly Fat"
    • 00:05:04 Three Competing Theories: How Visceral Fat Actually Causes Disease
    • 00:08:35 Adipokines: PAI-1, Angiotensinogen, and What Happens When Adiponectin Drops
    • 00:09:52 How to Measure: Three Sites That Don't Give the Same Number
    • 00:14:30 Clinical Thresholds, Ethnic Adjustments, and the Waist-to-Height Ratio
    • 00:15:45 The Weight-to-Waist Ratio: Tracking the Quality of Your Fat Loss
    • 00:19:20 Sleep, Cortisol, and Why the Hormonal Environment Has to Support the Work
    • 00:21:24 Why Exercise Reduces Visceral Fat 6× More Than Diet Alone
    • 00:22:02 Mechanism 1 — Beta-3 Adrenergic Receptors and Preferential Visceral Fat Mobilization
    • 00:24:10 Mechanism 2 — Myokines: The Fat-Burning Signal Only Contracting Muscle Can Send
    • 00:26:21 GLP-1 Agonists and Body Composition: What the Clinical Trials Actually Show
    • 00:28:05 DXA's Blind Spot: Myosteatosis, Glycogen, and Why Lean Mass Numbers Are Inflated
    • 00:30:10 SEMALEAN, the BELIEVE Trial, and the 1-in-10 Reality of Long-Term Lifestyle Programs
    • 00:33:15 Testosterone, Visceral Fat, and the Aromatase Feed-Forward Loop
    • 00:36:05 Three Testosterone Ranges: Deficient, Eugonadal, and Supraphysiological
    • 00:38:05 The Bhasin 4-Group Study — and Why AAS Are a Class, Not a Synonym for TRT
    • 00:39:33 Tesamorelin: The GHRH Analogue That Selectively Targets Visceral Fat
    • 00:40:53 Practical Framework: What to Measure, When, and What to Do
    • 00:43:20 Key Takeaways


    Next Steps


    • For evidence-based resistance training programs: barbellmedicine.com/training-programs
    • For individualized training consultation: barbellmedicine.com/coaching
    • Explore our full library of articles on health and performance: barbellmedicine.com/resources
    • To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/
    • To consult with Drs. Baraki or Feigenbaum email us at [email protected]
    • Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/


    Resources:


    • https://pubmed.ncbi.nlm.nih.gov/11502820/
    • https://pubmed.ncbi.nlm.nih.gov/33567185/
    • https://pubmed.ncbi.nlm.nih.gov/35658024/
    • https://pubmed.ncbi.nlm.nih.gov/40318682/
    • https://pubmed.ncbi.nlm.nih.gov/41068996/
    • https://pubmed.ncbi.nlm.nih.gov/41772149/
    • https://pubmed.ncbi.nlm.nih.gov/23944298/
    • https://pubmed.ncbi.nlm.nih.gov/20948519/
    • https://pubmed.ncbi.nlm.nih.gov/27213481/
    • https://pubmed.ncbi.nlm.nih.gov/23303913/


    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    17 March 2026, 1:00 pm
  • 1 hour 1 minute
    Episode #389: Your Liver Enzymes Are Elevated — But It Might Not Be Your Liver

    A fit, healthy 39-year-old was nearly sent for a liver biopsy. The cause? Was it that he went to the gym before every blood draw or because his supplement was throwing his labs off?. Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the blind spot that sends thousands of healthy athletes down an expensive, potentially unnecessary diagnostic rabbit hole every year.

    Timestamps:

    • 00:01:09  Introducing the Case
    • 00:03:44  How to Read a Liver Panel: ALT, AST, GGT, Alk Phos, Albumin Explained
    • 00:10:50  What Is GGT and Why Does It Matter Clinically?
    • 00:16:38  Why Exercise, Protein, and Creatine Aren't on the Differential (Yet)
    • 00:17:35  The Workup: Hepatitis Panels, Abdominal Ultrasound, and More
    • 00:19:42  Second Set of Labs — The Mystery Deepens
    • 00:25:25  Updated Differential: What's Still on the List?
    • 00:27:08  The Labs Normalize — A Critical Clue Appears
    • 00:31:40  The Reveal: Exercise Was the Cause All Along
    • 00:32:18  The Mechanism: How Exercise Elevates 'Liver' Enzymes
    • 00:32:54  Point 1 — ALT & AST Are Not Exclusively Liver Enzymes
    • 00:33:49  Point 2 — It's Unavoidable: 100% of Lifters Are Affected
    • 00:36:02  Point 3 — It Takes 10–12 Days to Normalize
    • 00:37:00  Point 4 — It's Mostly Harmless
    • 00:38:27  56% of Physicians Miss This Diagnosis
    • 00:38:48  Why Clinicians Overlook Exercise History
    • 00:44:01  Point 5 — GGT as the Differentiator (And Its Limits)
    • 00:46:42  Why Alkaline Phosphatase Also Rises Post-Workout
    • 00:48:51  The Cost of Missing Lifestyle Context: Over- and Under-Diagnosis
    • 00:53:29  What to Say to Your Doctor: 3 Patient Scripts
    • 00:59:31  5 Key Takeaways
    • 01:00:25  Final Advice from Dr. Baraki 


    Next Steps


    Resources:

    • Case: https://pubmed.ncbi.nlm.nih.gov/37025214/
    • https://pubmed.ncbi.nlm.nih.gov/29059178/ 
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC7438350/
    • https://pubmed.ncbi.nlm.nih.gov/18557801/
    • https://pubmed.ncbi.nlm.nih.gov/19209234/
    • https://pubmed.ncbi.nlm.nih.gov/11476029/
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC11165564/
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC12460594/ 
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC2291230/
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC11319523/ 
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC3936967/
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC12188904/
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC7969109/
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC11498664/
    • https://pmc.ncbi.nlm.nih.gov/articles/PMC3104191/


    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    9 March 2026, 9:48 pm
  • 34 minutes 4 seconds
    Episode #388: Muscle Imbalances, Red Meat Risk, and the Science of Body Fat Set Points

    In this special preview of the Barbell Medicine Plus Direct Line, Dr. Jordan Feigenbaum and Dr. Austin Baraki move past the fitness basics to tackle high-level technical nuances. We dive into the persistent myth of "muscle imbalances" and why your asymmetry might actually be a functional feature of your training.

    We also address the "meat" of the cardiovascular debate: is red meat and saturated fat consumption still risky if you are highly active and have a high-fiber diet? Finally, we explore the Dual Intervention Point Model to explain why the body defends its energy stores and how our environment has shifted the biological "set point" for body fat.

    Timestamps

    • 00:00 – Barbell Medicine Plus: Special Annual Membership Promotion
    • 01:03 – Muscle Imbalances: A Reliable Predictor of Pain?
    • 03:59 – Acuted vs. Gradually Acquired Asymmetries
    • 08:55 – How Coaches Should Manage "Alignment" Beliefs
    • 11:54 – Is Red Meat Necessary to Limit if You Are Otherwise Healthy?
    • 15:36 – The Role of Substitution: Plant vs. Animal Protein
    • 19:50 – Analyzing the Lean Mass Hyper-Responder (LMHR) Phenotype
    • 26:20 – The Dual Intervention Point Model of Body Fatness
    • 30:26 – Lipostat, Gravistat, and the Regulation of Energy Stores


    Next Steps


    Key Takeaways

    • Asymmetry as a Feature: Human bodies are not naturally symmetrical. In many athletes—such as tennis players, pitchers, or rowers—asymmetry is a functional adaptation to the sport's demands.
    • The Pathological vs. The Normal: Acutely acquired asymmetries (post-surgery or trauma) require specific clinical attention. Long-standing or gradually acquired asymmetries are rarely the primary driver of pain.
    • Saturated Fat & The Healthy User Bias: While fit individuals have a lower overall risk profile, elevated LDL and ApoB particles represent a "time-volume" exposure risk that should not be ignored based solely on lifestyle.
    • The Lean Mass Hyper-Responder (LMHR): We analyze the bold claims surrounding the LMHR phenotype and discuss why mechanistic hypothesizing currently lacks the "hard human outcome receipts" to prove long-term safety.
    • Body Fat Regulation: The Dual Intervention Point Model suggests the body defends a lower boundary (starvation) and an upper boundary (predation). In the modern environment, the "predation pressure" has vanished, leading to a genetic drift upward in body fat set points.






    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    26 February 2026, 9:41 pm
  • 1 hour 12 minutes
    Episode #387: The Valsalva Maneuver- Blood Pressure &amp; Safety in Lifting

    Most doctors, trainers, and "safety-first" influencers warn that holding your breath while lifting is a dangerous habit that could lead to a stroke or heart failure. By looking back at the 300-year history of the Valsalva maneuver—from a 1704 ear treatment to the "boogeyman" blood pressure studies of the 1980s—we dismantle the myth of the "fragile tube." Discover the science of the "pressurized suit" and why your body is actually designed to handle extreme internal pressure during heavy exertion.


    Key Takeaways

    • The 'Ear Trick' Origins: Originally described in 1704 by Antonio Maria Valsalva as a way to clear middle-ear infections, the maneuver wasn't linked to cardiovascular risk until the 1850s "Weber experiments."
    • The MacDougall 480/350 Study: Why the finding of massive blood pressure spikes during leg presses may have created a "villain arc" for the Valsalva maneuver in modern medicine.
    • Transmural Pressure Protection: A blood vessel fails when internal pressure significantly exceeds external support; during a Valsalva, the internal spike is matched by an external "cradle" of intra-thoracic and cerebrospinal fluid pressure.
    • Reflexive vs. Intentional Bracing: The Valsalva maneuver is a hard-wired reflex that triggers involuntarily at approximately 80% of a maximal voluntary contraction to stabilize the trunk.
    • Vascular Safety and Stroke Risk: Evidence suggests that for healthy populations, the risk of a vascular "pop" is negligible because the pressure gradient across the vessel wall (transmural pressure) remains stable.
    • Pregnancy and Fetal Safety: Clinical data on pregnant athletes shows that heavy, braced lifting up to 90% of a 10-rep max does not cause fetal distress or compromised uterine blood flow.
    • The 'Hissing' Safety Valve: For those prone to lightheadedness or pelvic floor symptoms, using a slow, active exhalation (a hiss) during the concentric phase can help manage pressure transitions.


    Timestamps


    • [00:00] History: From the 1704 Ear Treatise to the Weber Fainting Experiments
    • [05:26] The 1985 MacDougall Study: Origin of the "480/350" Blood Pressure Boogeyman
    • [06:22] The Anatomy of a Breath-Hold: The 4 Phases of the Valsalva Maneuver
    • [12:59] Reflexive Bracing: Why You Can’t Stop Yourself from Holding Your Breath
    • [28:24] The Pressurized Suit: Transmural Pressure and Vascular Safety
    • [31:00] The Brain and the Box: CSF Protection and Intracranial Pressure
    • [35:27] Heart Health: Does Lifting Cause Pathological Heart Thickening?
    • [41:17] Special Populations: Strokes, Aneurysms, and the 'Pop' Theory
    • [46:15] The Pelvic Floor: Stress Incontinence and the Weightlifter's Paradox
    • [49:34] Pregnancy: Monitoring Fetal Heart Rates During Heavy Braced Lifting
    • [56:42] Contraindications: When is the Valsalva Maneuver Actually Dangerous?


    Next Steps



    References



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    20 February 2026, 3:43 pm
  • 2 hours 17 seconds
    Episode #386: Longevity Myths- Biological Clocks, GLP-1 Muscle Loss, and What Actually Predicts Lifespan

    The longevity industry is now worth over $100 billion per year. From DNA methylation clocks to multi-cancer blood tests and GLP-1 medications, the promises are bold.

    But what actually predicts lifespan?

    In this episode, Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the science behind biological clocks, the real story on GLP-1–related muscle loss, and introduce the Barbell Medicine “Vital Five” — a clinically grounded framework for health and longevity.

    Key Points:


    • The Three Generations of Biological Clocks: Understanding the evolution of DNA methylation tests from simple chronological markers (Horvath) to sophisticated predictors of mortality (GrimAge) and functional decline (DunedinPACE).
    • Descriptive vs. Prescriptive Metrics: Why a biological age score acts as a lagging indicator rather than a tool for clinical decision-making, compared to traditional risk factors like blood pressure and ApoB.
    • GLP-1s and Sarcopenia Reality: A nuanced look at lean mass loss during semaglutide and tirzepatide treatment, emphasizing the difference between total lean mass and actual skeletal muscle quality.
    • Weight-Independent Benefits of Incretins: Analyzing data from the SELECT and FLOW trials regarding the direct cardioprotective and renal benefits of GLP-1 receptor agonists.
    • The Limitations of Early Detection: Why multi-cancer early detection (MCED) tests can lead to diagnostic loops and how clinical utility differs from marketing promises.
    • The Barbell Medicine Vital Five: A definitive framework for longevity focusing on blood pressure, ApoB, VO2 max, relative strength, and body composition.
    • Neurodegenerative Research Outlook: A critical review of the EVOKE trials and the potential (or lack thereof) for current weight-loss medications in treating established Alzheimer's disease.


    Next Steps



    Timestamps:


    • 00:00 Overview: longevity industry and proxy metrics
    • 01:06 Biological age and DNA methylation clocks
    • 08:18 Clinical usefulness and limitations of biological age testing
    • 16:16 Multi-cancer early detection tests: screening tradeoffs
    • 30:39 Exercise prescription for longevity (treat-to-target)
    • 54:39 Protein intake and longevity: evidence and recommendations
    • 1:07:23 GLP-1 receptor agonists: outcomes, misconceptions, and use cases
    • 1:34:24 Hormone therapy (women and men): risks, benefits, evidence
    • 1:49:19 Practical longevity tracking: “Vital Five” markers
    • 1:58:15 Closing


    References:



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    13 February 2026, 9:00 pm
  • 23 minutes 9 seconds
    How-To Fix Your Stalled Progress (Strength Edition)

    Lifting more weight doesn't always mean you've gotten stronger. In this foundational session, Dr. Jordan Feigenbaum and Dr. Austin Baraki introduce the Fitness-Fatigue Model to explain why "stalled" progress is often just a temporary masking of strength by accumulated fatigue. By learning to differentiate between a lack of fitness adaptation and a lack of recovery, you can avoid the "panic pivot" and maintain the long-term signal necessary for elite-level gains.

    Supercast Sign-Up

    For the 6-part audio series and Training Plateau Action Plan, sign-up for Barbell Medicine Plus:

    https://barbellmedicine.supercast.com/

    Key Learning Points

    • The Fitness-Fatigue Model: Understand the physiological duality of every workout—while a session builds your "fitness" (potential), it also creates "fatigue" that temporarily suppresses your performance.
    • Strength vs. Effort: Performance must be measured relative to RPE. If the weight on the bar increases but the RPE climbs disproportionately (e.g., jumping from RPE 8 to RPE 10 for a 5lb gain), your absolute strength has not actually improved.
    • Noise vs. Signal: A one-week stall is statistical "noise." Constant program hopping in response to a single bad session destroys the cumulative stimulus (the "signal") required for actual tissue adaptation.
    • The Root Cause Audit: Determining the "Why" behind a plateau.
    • Lack of Fitness: The stimulus is no longer sufficient to drive a new adaptation (Needs more volume/intensity).
    • Lack of Recovery: The fatigue is overwhelming the adaptation (Needs a deload or volume reduction).
    • Autoregulation as a Diagnostic Tool: Using RPE not just to prescribe load, but to "interrogate" your current state of recovery and readiness.


    Timestamps

    • [00:00] Intro: Introducing the Barbell Medicine Plus Exclusive Series
    • [02:15] The Thought Experiment: 310x6 @ 8 vs. 315x6 @ 10
    • [05:30] Deep Dive: Defining the Fitness-Fatigue Model
    • [09:45] Interpreting the Stall: Is it a Stimulus Problem or a Recovery Problem?
    • [14:20] The Danger of "Short-Termism": Why Panicking Destroys the Signal
    • [18:50] Introduction to the 6-Part Audio Course & Actionable PDF


    Pearls

    • The Pivot Rule: Never change a successful program based on a single week of data. Look for a 3-week trend of stagnant or declining performance (at the same RPE) before initiating a program pivot.
    • Peaking Mechanics: Most "peaking" protocols do not build new strength; they simply reduce fatigue to reveal the strength you've already built.
    • The stimulus-Recovery Trap: If you feel "beat up" but the weights are moving well, you likely don't need a deload yet. If you feel "great" but the weights are stuck, you likely need a stronger stimulus.


    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    6 February 2026, 1:00 pm
  • 53 minutes 17 seconds
    Episode #385- Why Grip Strength Predicts Death (And Why You Shouldn't Train It)

    Can a simple one-second squeeze predict your risk of cardiovascular disease, cognitive decline, and all-cause mortality? Dr. Jordan Feigenbaum and Dr. Austin Baraki explore why grip strength has become the go-to metric for the longevity industry and why most people are interpreting the data incorrectly.

    Timestamps:

    • [00:00] Intro: The Longevity Industry’s Thermometer Error
    • [01:42] The Neuro-Axis: Anatomy of a Maximal Squeeze
    • [06:43] The 35-3-5 Rule: Biomechanics of Grip
    • [09:12] Asymmetries and Clinical Red Flags
    • [17:31] Dynapenia vs. Sarcopenia: Why the Hand Fails First
    • [18:41] Normative Data and the PURE Study Statistics
    • [27:16] Genetics, Lean Body Mass, and Predictive Power
    • [31:44] Absolute vs. Relative Grip Strength (The Metabolic Signal)
    • [37:03] Bro-Science Beatdown: Neural Jitter and Training Readiness
    • [42:19] The Extensor Training and "Grip Maxing" Myth
    • [45:13] Programming: Systemic Training vs. Indirect Grip Work
    • [48:10] The Straps Debate: Are You Killing Your Gains?
    • [52:03] Final Verdict: Hierarchy and Health Priorities


    Key Takeaways:

    • Grip is Systemic: Handgrip strength tests the integrity of the entire system, from the motor cortex in the brain down to the tendons and bones. It is a proxy for overall muscular quality and neurological health.
    • Predictive Power: According to the PURE study, for every 5 kg decrease in grip strength, there is a 17% increased risk of cardiovascular death and a 7% increased risk of non-cardiovascular death.
    • The Sarcopenia Floor: Clinical "red zones" for probable sarcopenia are <27 kg for men and <16 kg for women.
    • Relative Strength Matters: Relative grip strength (Grip Strength ÷ BMI) is a more accurate predictor of hypertension, diabetes, and dyslipidemia than absolute grip strength alone.
    • Don't Chase the Test: Direct grip training (crushers, etc.) obscures the predictive power of the test. To improve health, focus on indirect systemic resistance training (training the whole body) rather than "gaming" the thermometer.


    Next Steps

    For evidence-based resistance training programs: barbellmedicine.com/training-programs

    For individualized medical and training consultation: barbellmedicine.com/coaching

    Explore our full library of articles on health and performance: barbellmedicine.com/resources

    To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/


    RESOURCES:



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    30 January 2026, 4:25 pm
  • 1 hour 3 minutes
    Episode 384: The Paralyzed Personal Trainer (Mystery Case)

    Dr. Feigenbaum and Dr. Baraki walk through the clinical workup of a 24 year old male presented with persistent weakness in his foot following weight loss of 22 pounds in two weeks. What could've possibly caused this?

    The discussion pivots to the science of how fast one should lose weight. While athletes should prioritize slow loss to preserve performance and lean mass, the data for individuals with obesity suggests that the speed of loss may be less critical than protein intake and resistance training.


    Timestamps:

    • 00:00 - The Case of the Paralyzed Personal Trainer 
    • 03:48 - How Doctors Build a Differential for Weakness 
    • 12:08 - Interpreting Negative Labs and MRI Results 
    • 15:04 - Identifying Foot Drop and Nerve Distribution 
    • 20:53 - Understanding Nerve Conduction and EMG Studies 
    • 26:06 - The Diagnosis: Slimmers Paralysis Explained 
    • 32:56 - Are GLP-1 Medications Increasing Nerve Injury Risks? 
    • 35:01 - Rapid vs Slow Weight Loss: Muscle Mass and Performance 
    • 41:27 - The Truth About Metabolic Adaptation and Weight Regain
    •  52:33 - New Research on Weight Regain After Stopping Medications 
    • 58:32 - Clinical Recommendations for Sustainable Weight Management


     Key Learning Points (SPOILER ALERT)

    • Slimmer’s Paralysis (Dieting Palsy): Discover how rapid fat loss depletes the protective structural fat pads at the fibular head, leaving the common peroneal nerve vulnerable to compression.
    • The "Two-Hit" Model: Understand how the combination of biological depletion (rapid weight loss) and mechanical provocation (aggressive stretching or squatting) triggers focal weakness.
    • Speed vs. Quality for Athletes: Evidence suggests that for trainees, a slower weight loss rate of $\sim$0.7% of body weight per week is superior for maintaining lean mass compared to faster rates.
    • Metabolic Adaptation as a Signature of Success: Why a reduction in resting metabolic rate is an unavoidable adaptive response to weight loss and not necessarily a predictor of future weight regain.
    • Diagnosing Focal Weakness: A step-by-step look at how clinicians differentiate between lumbar spine issues and peripheral nerve entrapment using physical exams and electrodiagnostic testing.


    Resources:

    Case: https://pubmed.ncbi.nlm.nih.gov/39809480/ 




    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    23 January 2026, 1:00 pm
  • 1 hour 16 minutes
    Episode #383: Scientific Populism vs. Consensus - The 2026 Food Pyramid


    In this episode, Dr. Jordan Feigenbaum and Dr. Austin Baraki dissect the federal government’s 2026 Food Pyramid Reset and its radical shift in nutrition policy. They explore the history of industry lobbying that shaped previous guidelines and evaluate whether the new emphasis on protein and animal fats aligns with current clinical evidence. Finally, the doctors provide the framework for the Barbell Medicine Dietary Guidelines, offering a practical, evidence-based framework for managing the modern food environment.


    Timestamps

    • 00:00 - Introduction: The 1992 Food Pyramid vs. the 2026 Reset
    • 03:11 - A History of Lobbying: From the McGovern Committee to the USDA
    • 09:44 - Big Food and Big Tobacco: How the American pantry was engineered
    • 17:15 - The Good: Protein floors and the official war on ultra-processed foods
    • 27:13 - The Bad: Saturated fat, beef tallow, and the dairy hall pass
    • 44:02 - The Ugly: The 25-gram fiber gap and the retreat on alcohol guidelines
    • 54:10 - Economic barriers and the Healthy Eating Index scores
    • 01:06:18 - The Barbell Medicine Dietary Guidelines: A practical framework


    Next Steps

    For evidence-based resistance training programs: barbellmedicine.com/training-programs

    For individualized medical and training consultation: barbellmedicine.com/coaching

    Explore our full library of articles on health and performance: barbellmedicine.com/resources

    To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/


    Key Learning Points

    1. Environment over Willpower: Weight gain is an emergent process caused by an engineered food environment that adds nearly 500 passive calories to the average American's daily intake compared to 1977.
    2. The New Protein Floor: The 2026 Reset finally acknowledges that the old 0.8g/kg RDA was a "survival dose." The new range of 1.2–1.6g/kg is a victory for skeletal muscle health, though doesn't really change intake for many (if they even read the guidelines).
    3. Incoherent Fat Logic: There is a fundamental conflict in guidelines that recommend beef tallow and butter while simultaneously advising that saturated fat stay below 10% of total calories.
    4. The Fiber Gap: By emphasizing animal proteins over legumes, the new guidelines risk widening the already massive fiber deficiency in the U.S.
    5. The 10:1 Rule: For better metabolic health, aim for a carbohydrate-to-fiber ratio of 10:1 (acceptable) or 5:1 (elite).


    References

    Barbell Medicine Guidelines Coming Soon! 



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    16 January 2026, 1:00 pm
  • More Episodes? Get the App